A study on male mice has shown that metformin can attenuate obesity-related asthma by inhibiting the TNF-α-induced inflammatory signaling and NF-κB-mediated iNOS expression in lung tissues (Calixto et al., 2013). Here, NFKB1 is linked to obesity due to melanocortin 4 receptor deficiency.